MoneyWorks4Me

Hester Biosciences - Quaterly Results

01 Aug 2025 Evaluate
The sales is pegged at Rs. 634.90 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 734.66 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 78.38  millions from Rs. 84.32 millions ,decline by -7.04%.Operating Profit reported a sharp decline to 133.57 millions from 145.54 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 634.90 734.66 -13.58 634.90 734.66 -13.58 2864.66 2851.55 0.46
Other Income 9.46 10.57 -10.50 9.46 10.57 -10.50 47.64 42.62 11.78
PBIDT 133.57 145.54 -8.22 133.57 145.54 -8.22 557.08 516.03 7.95
Interest 9.05 11.26 -19.63 9.05 11.26 -19.63 53.67 50.93 5.38
PBDT 124.52 134.28 -7.27 124.52 134.28 -7.27 503.41 465.10 8.24
Depreciation 21.64 21.23 1.93 21.64 21.23 1.93 85.81 97.78 -12.24
PBT 102.88 113.05 -9.00 102.88 113.05 -9.00 417.60 367.32 13.69
TAX 24.50 28.73 -14.72 24.50 28.73 -14.72 99.18 95.73 3.60
Deferred Tax 6.12 0.02 30500.00 6.12 0.02 30500.00 -13.52 -0.62 2080.65
PAT 78.38 84.32 -7.04 78.38 84.32 -7.04 318.42 271.59 17.24
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 21.04 19.81 6.20 21.04 19.81 6.20 19.45 18.10 7.46
Peers
Company Name CMP
Sun Pharma. Inds. 1850.20
Dr. Reddys Labs. 1210.65
Cipla 1374.50
Lupin 2095.55
Zydus Lifesciences 1162.00
View more..